Re: Bladder Wall Thickness in Women with Symptoms of Overactive Bladder and Detrusor Overactivity: Results from the Randomised, Placebo-Controlled SHRINK Study

被引：0
|
作者：
Wein, Alan J.
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 02期
关键词：
D O I：
10.1016/j.juro.2017.11.053
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [41] The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women is consistent with symptom improvement
    不详
    BJU INTERNATIONAL, 2010, 106 : 6 - 6
  • [42] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [43] Solifenacin demonstrates rapid improvement of urgency in overactive bladder syndrome: Results from a randomised, double-blind, placebo-controlled, rising-dose study
    Cardozo, L.
    Balaz, V.
    Trapeznikova, M.
    Mokris, J.
    Van Erps, P.
    Wolski, Z.
    Drogendijk, T.
    Wright, M.
    Bolodeoku, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 204 - 204
  • [44] Re: Bladder Wall Micromotion Measured by Non-Invasive Ultrasound: Initial Results in Women with and without Overactive Bladder
    Nagle, A. S.
    Cullingsworth, Z. E.
    Li, R.
    Carucci, L. R.
    Klausner, A. P.
    Speich, J. E.
    JOURNAL OF UROLOGY, 2021, 206 (04): : 1068 - 1069
  • [45] Does Urodynamic Verification of Overactive Bladder Determine Treatment Success? Results From a Randomized Placebo-Controlled Study Editorial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 647 - 648
  • [46] Overactive bladder syndrome: Is a request for a dose increase indicative of more severe symptoms? Results from a randomised, double-blind, placebo-controlled, risfng-dose study of solifenacin (SUNRISE)
    Cardozo, L.
    Avdoshin, V
    Wolski, Z.
    Pavlik, I
    Sofras, F. E.
    Toth, Z.
    Vasco, P. M.
    Drogendijk, T.
    Wright, D. M.
    Bolodeoku, J.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 : S68 - S69
  • [47] Effect of mirabegron on cognitive function in elderly patients with overactive bladder: Results from a Phase 4 placebo-controlled study (PILLAR)
    Griebling, T.
    Campbell, N.
    Mangel, J.
    Staskin, D.
    Herschorn, S.
    Elsouda, D.
    Schermer, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S218 - S219
  • [48] A randomized placebo-controlled study of the efficacy of antimuscarinics in the treatment of pediatric overactive bladder and incontinence
    Steve J. Hodges
    Anthony Atala
    Current Urology Reports, 2009, 10 (1) : 6 - 7
  • [49] Re: Bhide AA et al. Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study
    Valdevenito, Juan Pablo
    Olea, Mauricio
    Mercado-Campero, Alejandro
    CONTINENCE, 2024, 9
  • [50] Patients with overactive bladder show progressive improvement in urgency and bladder condition during treatment with solifenacin in a randomised, double-blind, placebo-controlled study (SUNRISE)
    Cardozo, L.
    Adamik, Z.
    Guimaraes, M.
    Krhut, J.
    Labat, J.-J.
    Petrov, S.
    Drogendijk, T.
    Wright, D. M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 : S67 - S68
12345